Related Experiment Video

Updated: Aug 24, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model

Radhakrishnan P Iyer1, Arlene Roland, Yi Jin

  • 1Origenix Techonologies, Inc., St. Laurent, Quebec, Canada.

Antimicrobial Agents and Chemotherapy
|May 25, 2004
PubMed

Abstract:

ORI-9020, a novel dinucleotide, evaluated in transgenic mice expressing hepatitis B virus (HBV), significantly reduced liver HBV DNA (P

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: Aug 24, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Articles linked to this work by shared authors, journal, and citation graph.

BDAA, a yellow fever virus NS4B inhibitor, is effective during therapeutic treatment in a hamster model of yellow fever.

Antiviral research·2026

Exploring shared molecular pathways and gene signatures in type 2 diabetes mellitus and Alzheimer's disease in a Pakistani cohort.

Journal of Alzheimer's disease reports·2026

In Vivo Efficacy of a Broad-Spectrum Antiviral Combination Against Yellow Fever in a Hamster Model.

Pathogens (Basel, Switzerland)·2025

Epidemiological Investigation on the Clinical Status of the Developmental Dyslexia and ADHD Comorbidity among School-Age Children in Pakistan.

Open journal of epidemiology·2025

Structure-Activity Relationship Studies Towards Analogues of Pleconaril as Novel Enterovirus-D68 Capsid-Targeting Antivirals.

bioRxiv : the preprint server for biology·2025

Structural elucidation of a unique binding mode by an intact alphavirus human IgG molecule to a quaternary epitope.

Nature communications·2025

In vitro in-depth characterization of emodepside in combination with key anthelmintic drugs on soil-transmitted helminths.

Antimicrobial agents and chemotherapy·2026

Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis.

Antimicrobial agents and chemotherapy·2026

Efflux reprogramming promotes Staphylococcus aureus persistence with Pseudomonas aeruginosa in cystic fibrosis.

Antimicrobial agents and chemotherapy·2026

A gene network regulating echinocandin heteroresistance in Candida glabrata.

Antimicrobial agents and chemotherapy·2026

Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV.

Antimicrobial agents and chemotherapy·2026

Development and validation of a cefepime population pharmacokinetic model to guide treatment for patients with hospital-acquired pneumonia requiring renal replacement.

Antimicrobial agents and chemotherapy·2026

Diagnostic challenge of pulmonary embolism during testosterone replacement therapy for primary hypogonadism.

JCEM case reports·2026

A roadmap for modernizing vaccine safety assessment: Challenges and opportunities for new approach methodologies.

ALTEX·2026

Post-treatment risks of transcatheter aortic valve implantation: should we be increasing preventative measures?

Expert review of cardiovascular therapy·2026

In vivo antiviral efficacy and safety of 5-hydroxymethyltubercidin against DENV2 and SARS-CoV-2.

Virus research·2026

MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions.

Journal of neuro-oncology·2026

[Chances and challenges in the prevention and treatment of early childhood hearing loss: the AWMF guideline on congenital CMV infection].

HNO·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us